The global Noninvasive Prenatal Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down's syndrome, Edwards syndrome, Turner syndrome and Pato syndrome.
This report aims to provide a comprehensive presentation of the global market for Noninvasive Prenatal Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Noninvasive Prenatal Diagnostics. This report contains market size and forecasts of Noninvasive Prenatal Diagnostics in global, including the following market information:
- Global Noninvasive Prenatal Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
North America has the largest share of the noninvasive prenatal diagnostics market, with Asia Pacific and the Middle East achieving the fastest growth.
We surveyed the Noninvasive Prenatal Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Noninvasive Prenatal Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Noninvasive Prenatal Diagnostics Market Segment Percentages, by Type, 2022 (%)
Global Noninvasive Prenatal Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Noninvasive Prenatal Diagnostics Market Segment Percentages, by Application, 2022 (%)
Global Noninvasive Prenatal Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Noninvasive Prenatal Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Noninvasive Prenatal Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Noninvasive Prenatal Diagnostics revenues share in global market, 2022 (%)
Key players include:
- Natera
- Illumina
- BGI Diagnosis
- Ariosa Diagnostics
- Quest Diagnostics
- Premaitha Health
- NIPD Genetics
- Labcorp
- Ravgen
- LifeCodexx
- TrovaGene
- Quest Diagnostics
- Berry Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Noninvasive Prenatal Diagnostics, market overview.
Chapter 2: Global Noninvasive Prenatal Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Noninvasive Prenatal Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Noninvasive Prenatal Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Noninvasive Prenatal Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Noninvasive Prenatal Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Noninvasive Prenatal Diagnostics Overall Market Size
2.1 Global Noninvasive Prenatal Diagnostics Market Size: 2022 VS 2030
2.2 Global Noninvasive Prenatal Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Noninvasive Prenatal Diagnostics Players in Global Market
3.2 Top Global Noninvasive Prenatal Diagnostics Companies Ranked by Revenue
3.3 Global Noninvasive Prenatal Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Noninvasive Prenatal Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Noninvasive Prenatal Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Noninvasive Prenatal Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Noninvasive Prenatal Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Services
4.1.3 Instrument
4.2 By Type - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Noninvasive Prenatal Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Noninvasive Prenatal Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Noninvasive Prenatal Diagnostics Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Personal
5.1.4 Other
5.2 By Application - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Noninvasive Prenatal Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Noninvasive Prenatal Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Noninvasive Prenatal Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Noninvasive Prenatal Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Noninvasive Prenatal Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Noninvasive Prenatal Diagnostics Revenue, 2018-2030
6.3.2 US Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.3.3 Canada Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.3.4 Mexico Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Noninvasive Prenatal Diagnostics Revenue, 2018-2030
6.4.2 Germany Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.4.3 France Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.4.4 U.K. Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.4.5 Italy Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.4.6 Russia Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.4.8 Benelux Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Noninvasive Prenatal Diagnostics Revenue, 2018-2030
6.5.2 China Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.5.3 Japan Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.5.4 South Korea Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.5.6 India Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Noninvasive Prenatal Diagnostics Revenue, 2018-2030
6.6.2 Brazil Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.6.3 Argentina Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, 2018-2030
6.7.2 Turkey Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.7.3 Israel Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Noninvasive Prenatal Diagnostics Market Size, 2018-2030
6.7.5 UAE Noninvasive Prenatal Diagnostics Market Size, 2018-2030
7 Noninvasive Prenatal Diagnostics Companies Profiles
7.1 Natera
7.1.1 Natera Company Summary
7.1.2 Natera Business Overview
7.1.3 Natera Noninvasive Prenatal Diagnostics Major Product Offerings
7.1.4 Natera Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Natera Key News & Latest Developments
7.2 Illumina
7.2.1 Illumina Company Summary
7.2.2 Illumina Business Overview
7.2.3 Illumina Noninvasive Prenatal Diagnostics Major Product Offerings
7.2.4 Illumina Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Illumina Key News & Latest Developments
7.3 BGI Diagnosis
7.3.1 BGI Diagnosis Company Summary
7.3.2 BGI Diagnosis Business Overview
7.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Major Product Offerings
7.3.4 BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.3.5 BGI Diagnosis Key News & Latest Developments
7.4 Ariosa Diagnostics
7.4.1 Ariosa Diagnostics Company Summary
7.4.2 Ariosa Diagnostics Business Overview
7.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
7.4.4 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Ariosa Diagnostics Key News & Latest Developments
7.5 Quest Diagnostics
7.5.1 Quest Diagnostics Company Summary
7.5.2 Quest Diagnostics Business Overview
7.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
7.5.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Quest Diagnostics Key News & Latest Developments
7.6 Premaitha Health
7.6.1 Premaitha Health Company Summary
7.6.2 Premaitha Health Business Overview
7.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Major Product Offerings
7.6.4 Premaitha Health Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Premaitha Health Key News & Latest Developments
7.7 NIPD Genetics
7.7.1 NIPD Genetics Company Summary
7.7.2 NIPD Genetics Business Overview
7.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Major Product Offerings
7.7.4 NIPD Genetics Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.7.5 NIPD Genetics Key News & Latest Developments
7.8 Labcorp
7.8.1 Labcorp Company Summary
7.8.2 Labcorp Business Overview
7.8.3 Labcorp Noninvasive Prenatal Diagnostics Major Product Offerings
7.8.4 Labcorp Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Labcorp Key News & Latest Developments
7.9 Ravgen
7.9.1 Ravgen Company Summary
7.9.2 Ravgen Business Overview
7.9.3 Ravgen Noninvasive Prenatal Diagnostics Major Product Offerings
7.9.4 Ravgen Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Ravgen Key News & Latest Developments
7.10 LifeCodexx
7.10.1 LifeCodexx Company Summary
7.10.2 LifeCodexx Business Overview
7.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Major Product Offerings
7.10.4 LifeCodexx Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.10.5 LifeCodexx Key News & Latest Developments
7.11 TrovaGene
7.11.1 TrovaGene Company Summary
7.11.2 TrovaGene Business Overview
7.11.3 TrovaGene Noninvasive Prenatal Diagnostics Major Product Offerings
7.11.4 TrovaGene Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.11.5 TrovaGene Key News & Latest Developments
7.12 Quest Diagnostics
7.12.1 Quest Diagnostics Company Summary
7.12.2 Quest Diagnostics Business Overview
7.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
7.12.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.12.5 Quest Diagnostics Key News & Latest Developments
7.13 Berry Genomics
7.13.1 Berry Genomics Company Summary
7.13.2 Berry Genomics Business Overview
7.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Major Product Offerings
7.13.4 Berry Genomics Noninvasive Prenatal Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Berry Genomics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Noninvasive Prenatal Diagnostics Market Opportunities & Trends in Global Market
Table 2. Noninvasive Prenatal Diagnostics Market Drivers in Global Market
Table 3. Noninvasive Prenatal Diagnostics Market Restraints in Global Market
Table 4. Key Players of Noninvasive Prenatal Diagnostics in Global Market
Table 5. Top Noninvasive Prenatal Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Noninvasive Prenatal Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Noninvasive Prenatal Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Noninvasive Prenatal Diagnostics Product Type
Table 9. List of Global Tier 1 Noninvasive Prenatal Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Noninvasive Prenatal Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Noninvasive Prenatal Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Natera Company Summary
Table 31. Natera Noninvasive Prenatal Diagnostics Product Offerings
Table 32. Natera Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Natera Key News & Latest Developments
Table 34. Illumina Company Summary
Table 35. Illumina Noninvasive Prenatal Diagnostics Product Offerings
Table 36. Illumina Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Illumina Key News & Latest Developments
Table 38. BGI Diagnosis Company Summary
Table 39. BGI Diagnosis Noninvasive Prenatal Diagnostics Product Offerings
Table 40. BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. BGI Diagnosis Key News & Latest Developments
Table 42. Ariosa Diagnostics Company Summary
Table 43. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product Offerings
Table 44. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Ariosa Diagnostics Key News & Latest Developments
Table 46. Quest Diagnostics Company Summary
Table 47. Quest Diagnostics Noninvasive Prenatal Diagnostics Product Offerings
Table 48. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Quest Diagnostics Key News & Latest Developments
Table 50. Premaitha Health Company Summary
Table 51. Premaitha Health Noninvasive Prenatal Diagnostics Product Offerings
Table 52. Premaitha Health Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Premaitha Health Key News & Latest Developments
Table 54. NIPD Genetics Company Summary
Table 55. NIPD Genetics Noninvasive Prenatal Diagnostics Product Offerings
Table 56. NIPD Genetics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. NIPD Genetics Key News & Latest Developments
Table 58. Labcorp Company Summary
Table 59. Labcorp Noninvasive Prenatal Diagnostics Product Offerings
Table 60. Labcorp Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Labcorp Key News & Latest Developments
Table 62. Ravgen Company Summary
Table 63. Ravgen Noninvasive Prenatal Diagnostics Product Offerings
Table 64. Ravgen Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Ravgen Key News & Latest Developments
Table 66. LifeCodexx Company Summary
Table 67. LifeCodexx Noninvasive Prenatal Diagnostics Product Offerings
Table 68. LifeCodexx Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. LifeCodexx Key News & Latest Developments
Table 70. TrovaGene Company Summary
Table 71. TrovaGene Noninvasive Prenatal Diagnostics Product Offerings
Table 72. TrovaGene Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. TrovaGene Key News & Latest Developments
Table 74. Quest Diagnostics Company Summary
Table 75. Quest Diagnostics Noninvasive Prenatal Diagnostics Product Offerings
Table 76. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 77. Quest Diagnostics Key News & Latest Developments
Table 78. Berry Genomics Company Summary
Table 79. Berry Genomics Noninvasive Prenatal Diagnostics Product Offerings
Table 80. Berry Genomics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 81. Berry Genomics Key News & Latest Developments
List of Figures
Figure 1. Noninvasive Prenatal Diagnostics Segment by Type in 2022
Figure 2. Noninvasive Prenatal Diagnostics Segment by Application in 2022
Figure 3. Global Noninvasive Prenatal Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Noninvasive Prenatal Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Noninvasive Prenatal Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Noninvasive Prenatal Diagnostics Revenue in 2022
Figure 8. By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Natera Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Illumina Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Premaitha Health Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. NIPD Genetics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Labcorp Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ravgen Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. LifeCodexx Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. TrovaGene Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Berry Genomics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
